The Enzen Trial: Comparison of Evar Endoprosthesis: Endurant Versus Zenith (ENZEN)

Hospital do Servidor Publico Estadual

Status: Active, not recruiting

Conditions: Aortoiliac Atherosclerosis; Aortic Aneurysm

Treatments: Device: EVAR

Study type: Observational

Funder types: Other

Identifiers

NCT05969782

32380920.5.0000.5463

Details and patient eligibility

About

A prospective, non-randomized trial of patients submitted to EVAR for aortoiliac aneursym using Endurant II (Medtronic) or Zenith (Cook).

Full description

A prospective, non-randomized trial of patients submitted to EVAR for aortoiliac aneursym using Endurant II (Medtronic) or Zenith (Cook).

The patients will be evaluated in a follow-up, regarding overall mortality rate, perioperative mortality rate and outcomes, such as Endoleaks and reinterventions.

Enrollment: 100 estimated patients

Sex: All

Ages: 40+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: Aortoiliac infra-renal aneurysms.

Exclusion Criteria: Thoracoabdominal aortic aneurysms, pararenal and supra-renal aortic aneurysms

• Patients not suitable for EVAR.

Trial design

100 participants in 2 patient groups

Endurant II

Description:

Patients with aortoiliac aneurysm submitted to EVAR with Endurant II.

Treatment:

Device: EVAR

Zenith

Description:

Patients with aortoiliac aneurysm submitted to EVAR with Zenith.

Treatment:

Device: EVAR